CompanyDrug

Worg Pharmaceuticals Gets FDA Approval for Phase II Graves’ Disease Study

CompanyDrug

Nanchang Baiji Pharmaceutical’s Budesonide Nasal Spray Approved by China’s NMPA

CompanyDrug

Eli Lilly’s Jaypirca Receives FDA Accelerated Approval for Chronic Lymphocytic Leukemia

CompanyDeals

Autobio Diagnostics and China National Medical Device Form Strategic Partnership

CompanyMedical Device

Valgen Secures NMPA Approval for China’s First Transcatheter Mitral Valve Clamp System

CompanyDrug

Ambio Gains FDA Approval for Generic Forteo, Challenging Eli Lilly’s Osteoporosis Market

CompanyDrug

Chinese Firms Secure EUAs for Omicron XBB Vaccines Amid Dominant Variant Surge

CompanyDrug

Pfizer’s Danuglipron Phase IIb Trial Achieves Weight Loss Goals Amid Tolerability Concerns

CompanyDrug

Everest Medicines Secures IND Review for Zetomipzomib in China

CompanyDrug

Sunshine Guojian’s SSGJ-608 Meets Phase III Efficacy Endpoints in Psoriasis Trial

Company

Novartis Invests USD 86.4 Million in New Radiotherapy Facility in China

CompanyDeals

AbbVie to Acquire ImmunoGen for USD 10.1 Billion, Expanding Oncology Portfolio